Filing Details
- Accession Number:
- 0001479290-23-000080
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-06-20 16:25:04
- Reporting Period:
- 2023-06-15
- Accepted Time:
- 2023-06-20 16:25:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1479290 | Revance Therapeutics Inc. | RVNC | Pharmaceutical Preparations (2834) | 770551645 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1848717 | Oconnor Carey Kolaja | C/O Revance Therapeutics, Inc 1222 Demonbreun Street, 20Th Floor Nashville TN 37203 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-06-15 | 2,500 | $18.12 | 19,061 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-06-15 | 2,500 | $28.24 | 16,561 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to buy) | Disposition | 2023-06-15 | 2,500 | $0.00 | 2,500 | $18.12 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 8,256 | 2032-05-03 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan dated March 16, 2023 by Ms. Kolaja.
- The shares subject to the stock option vested on May 4, 2023.
Billionaire Hedge Funds
